Health systems address RPM, wearable challenges: We explore new toolkits for scaling RPM adoption, and discuss how healthcare organizations can solve the challenges in adopting the devices.
We unpack how Optum’s M&A streak contributed to its sky-high revenues—but economic downturn could mean higher premiums for customers.
We think its latest Northwell Health partnership is a sign that more health systems could tap Google Cloud as patient data volume grows significantly.
Unlike competitors, CVS plans to rely heavily on physicians to power its new full-scale primary care clinics.
On today's episode, we discuss what Google is up to in the healthcare space: how Google is turning Search and YouTube into consumer health tools, how it could disrupt electronic health records, and what Google's relationship with healthcare will look like in five years. "In Other News," we talk about AI scanning medical records to improve your health and whether digital health startups are living up to their hype. Tune in to the discussion with our analysts Lisa Phillips and Rajiv Leventhal.
Investors’ interest in Series A funding rounds remains unwavered, according to Rock Health’s latest report. We detail what type of startups could continue seeing investment dollars amid a looming recession.
It’s rebranding to Twill and combining its digital therapy solutions as DTx makers pivot away from point-solutions to provide more precise care for pharma cos, employers, and insurers.
AI catches diabetes that would otherwise go undetected: Using a single retinal image from each eye, the tech can diagnose diabetes at far earlier stages than human doctors.
Over 20% of US adults received a surprise medical bill this year despite the Act going into effect in January. But price transparency rules and state-led initiatives could prevent unexpected bills.
We highlight Teladoc’s platform update and unpack why telehealth firms may scramble to retain consumers as COVID-19 becomes less urgent.
Over the past year, 22% of US adults have had to forgo prescription medications due to the cost. About one-quarter needed to see a doctor but could not afford it.
Home care company Tomorrow Health just scored $60M, but the outlook for the rest of the year looks gloomy for Tomorrow and its peers as investors caution amid economic uncertainty.
AliveCor’s tech could be a more accessible option for clinical research as the ITC weighs a ban of Apple Watches after an EKG patent violation.
Health tech companies have reeled in billions in VC funding with promises to boost health outcomes and lower costs—but a new study sheds light on the lack of clinical outcomes they actually generate.
Ro is the latest startup to lay off a large chunk of its employee base amid economic uncertainty and fewer VC funding hauls.
11 Times SquareNew York, NY 100361-800-405-0844